Evaluation of tolerability and reactions of immune checkpoint inhibitors.

dc.contributor.authorSever, Ozlem Nuray
dc.contributor.authorSonmez, Ozlem
dc.contributor.authorDemir, Osman Gokhan
dc.date.accessioned2025-10-16T15:27:19Z
dc.date.issued2017
dc.description.abstract53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Chicago, IL, JUN 02-07, 2017
dc.identifier.doi10.1200/JCO.2017.35.15\_suppl.e14605
dc.identifier.otherWOS:000411895706143
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8510
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.sourceJOURNAL OF CLINICAL ONCOLOGY
dc.titleEvaluation of tolerability and reactions of immune checkpoint inhibitors.
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar